UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell ...

Vadodara: Sun Pharmaceutical Industries Limited's investee company, Lyndra Therapeutics Inc., has ceased operations due to ...

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.

Sun Pharma shares dipped in the intraday trading session on Friday, March 28. The Indian equity markets are in a tight spot, ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 9.91% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

In New Jersey, new initiatives support investment and job growth in the artificial intelligence and film and digital media ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

With Sun Pharmaceutical Industries currently trading at Rs 1786.50, the stock has demonstrated strong momentum, supported by ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...